Compared to Estimates, Cinemark (CNK) Q3 Earnings: A Look at Key Metrics

Zacks
Abrir em Zacks
Compared to Estimates, Cinemark (CNK) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2026, Cinemark Holdings (CNK) reported revenue of $1.06 billion, up 23.5% over the same period last year. EPS came in at $1.04, compared to $0.40 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $1.03 billion, representing a surprise of +2.36%. The company delivered an EPS surprise of +7.22%, with the consensus EPS estimate being $0.97.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Cinemark performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Average ticket price - U.S. Operating Segment: $11.16 versus $11.00 estimated by four analysts on average. Average ticket price - International Operating Segment: $4.32 versus $4.10 estimated by four analysts on average. Concession revenues per patron - U.S. Operating Segment: $8.66 compared to the $8.53 average estimate based on four analysts. Attendance - International Operating Segment: 26.3 million versus the four-analyst average estimate of 23.03 million. Revenue- U.S. Operating Segment- Admissions: $417.3 million versus the four-analyst average estimate of $411.65 million. The reported number represents a year-over-year change of +19.7%. Revenue- International Operating Segment- Admissions: $113.5 million compared to the $94.49 million average estimate based on four analysts. The reported number represents a change of +39.8% year over year. Revenue- U.S. Operating Segment- Concession: $323.8 million compared to the $318.9 million average estimate based on four analysts. The reported number represents a change of +18.9% year over year. Revenue- International Operating Segment- Concession: $90.1 million versus $72.72 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +40.1% change. Total revenue- U.S.: $817.5 million versus the three-analyst average estimate of $790.4 million. The reported number represents a year-over-year change of +19.6%. Revenue- Admissions: $530.8 million versus the six-analyst average estimate of $510.94 million. The reported number represents a year-over-year change of +23.5%. Revenue- Other: $114.4 million compared to the $103.77 million average estimate based on six analysts. The reported number represents a change of +25.6% year over year. Revenue- Concession: $413.9 million compared to the $400.61 million average estimate based on six analysts. The reported number represents a change of +22.9% year over year.

View all Key Company Metrics for Cinemark here>>>

Shares of Cinemark have returned +7.7% over the past month versus the Zacks S&P 500 composite's -2.3% change. The stock currently has a Zacks Rank #1 (Strong Buy), indicating that it could outperform the broader market in the near term.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Cinemark Holdings Inc (CNK): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research